The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection
Recruiting
N/A
Interventional Study
Helicobacter Infection
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 600 (estimated)
- Sponsor
- Seoul National University Bundang Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To compare the eradication success rate between 10-days sequential therapy and 7-days tailored therapy based on H. pylori culture and antimicrobial susceptibility testing.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* The patients who proved H. pylori infection following three methods
1. positive rapid urease test (CLOtest)
2. histologic evidence of H. pylori by modified Giemsa staining
3. positive Urea breath test
* Male and female Korean Adult (Aged ≥ 18 years)
Exclusion Criteria:…
Contacts